Rare diseases
Investigational molecules
Locations
Back to France97 clinical trials in Pau, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer
FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceStudy on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy
FranceStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations
FranceStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma
FranceStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
FranceA Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes
FranceComparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer
FranceStudy of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy
FranceStudy on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on colorectal cancer, breast cancer, and lung cancer treatments. Studies evaluating targeted therapies and immunotherapy combinations for better patient outcomes.
Several trials are exploring personalized treatment approaches based on genetic markers and patient response.
Research initiatives examining atherosclerotic cardiovascular disease and innovative approaches to hypertension management. Studies focusing on antiplatelet therapy optimization.
Trials are evaluating both established and novel therapeutic approaches for heart conditions.
Clinical investigations into rheumatoid arthritis and multiple sclerosis treatments. Studies evaluating combination therapies and treatment de-escalation strategies.
Research focuses on improving long-term outcomes while optimizing treatment protocols.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
